What happened
Shares of Clovis Oncology (NASDAQ: CLVS) headed for the moon on Tuesday after the company reported positive interim phase 1/2 clinical trial results for one of its therapies on June 14, with its shares up by more than 65% as of 11 a.m. ET today before pulling back s
Why Clovis Oncology Stock Is Blasting Off Today
More Stories
European stocks bounce off lowest in more than a year after Powell remarks
Dow Shares Slammed on Downgrade at Credit Suisse on Overearning Concerns
Israel stocks lower at close of trade; TA 35 down 0.17%